A reference to lab values, and to who sets the targetsHow we verifyHidden costsDealsAbout
OptimizeBiomarkers

Sources/Institution or study

NCEP ATP III (NHLBI, 2001)

Named as the source for 4 optimal-range positions across 4 biomarkers on this site. How we verify ranges.

01

Every position on this site

One row per marker. The comparison column uses the same simple-range parser the rest of the site does, so it is left blank rather than guessed when a range is tiered, sex-split, or in a different unit than the lab interval.

MarkerTheir rangeVs. the lab reference intervalWhere they stated it
HDL Cholesterol≥60 mg/dLnot directly comparableCited document ↗ATP III classifies 60 mg/dL or above as high and counts it as a negative risk factor; below 40 mg/dL is classified low.
LDL Cholesterol<100 mg/dL optimal; 100-129 near or above optimalnot directly comparableCited document ↗ATP III classes 130-159 as borderline high, 160-189 high and 190 or more very high
Non-HDL Cholesterol<130 mg/dL with CHD or a risk equivalent; <160 with 2+ risk factors; <190 with 0-1not directly comparableCited document ↗ATP III sets the non-HDL goal 30 mg/dL above the LDL goal for each risk tier, as a secondary target when triglycerides are 200 mg/dL or higher.
Triglycerides<150 mg/dL normalnot directly comparableCited document ↗ATP III classes 150-199 as borderline high and 200-499 as high

4 verified positions shown. Every row above either links to the optimal-ranges document named in our biomarker data or passed the expert-range verification described here; unverified or withheld claims never render.

Not medical advice. © 2026 Ocean Path Ventures LLC.

The monthly dispatch

Price changes, new sources, corrected ranges.

Once a month. Every change we made to the site, and why.